Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.13B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.04B |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$250M |
| 5 |
Meta Platforms (Facebook)
META
|
+$179M |
Top Sells
| 1 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$439M |
| 2 |
Microsoft
MSFT
|
+$412M |
| 3 |
Intel
INTC
|
+$386M |
| 4 |
Mercado Libre
MELI
|
+$358M |
| 5 |
Palo Alto Networks
PANW
|
+$345M |
Sector Composition
| 1 | Technology | 18.03% |
| 2 | Healthcare | 10.88% |
| 3 | Financials | 8.99% |
| 4 | Consumer Discretionary | 8.8% |
| 5 | Industrials | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Charles River Laboratories
CRL
$7.58B
| $6M | ﹤0.01% |
29,720
+10,830
| +57% | +$2.19M |
|
1027
Coherus Oncology, Inc. Common Stock
CHRS
$149M
| $5.95M | ﹤0.01% |
869,313
+102,229
| +13% | +$699K |
|
1028
Light & Wonder
LNW
$7.48B
| $5.95M | ﹤0.01% |
99,003
-4,801
| -5% | -$288K |
|
1029
NovoCure
NVCR
$1.37B
| $5.94M | ﹤0.01% |
98,835
-4,167
| -4% | -$251K |
|
1030
Fomento Económico Mexicano
FMX
$31.6B
| $5.94M | ﹤0.01% |
62,415
-27,792
| -31% | -$2.65M |
|
1031
Axalta
AXTA
$6.8B
| $5.93M | ﹤0.01% |
195,812
+77,869
| +66% | +$2.36M |
|
1032
Arrowhead Research
ARWR
$4.23B
| $5.92M | ﹤0.01% |
232,908
+95,568
| +70% | +$2.43M |
|
|
MRTX
1033
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.91M | ﹤0.01% |
158,993
+36,279
| +30% | +$1.35M |
|
1034
Old Republic International
ORI
$10B
| $5.9M | ﹤0.01% |
236,433
+59,792
| +34% | +$1.49M |
|
1035
DaVita
DVA
$9.53B
| $5.89M | ﹤0.01% |
72,672
-16,202
| -18% | -$1.31M |
|
1036
Albertsons Companies
ACI
$10.5B
| $5.87M | ﹤0.01% |
282,514
-29,512
| -9% | -$613K |
|
1037
Relay Therapeutics
RLAY
$697M
| $5.87M | ﹤0.01% |
356,112
+146,872
| +70% | +$2.42M |
|
|
ICNC
1038
DELISTED
Iconic Sports Acquisition Corp.
ICNC
| $5.85M | ﹤0.01% |
556,765
-68,887
| -11% | -$724K |
|
1039
Global X Lithium & Battery Tech ETF
LIT
$1.14B
| $5.85M | ﹤0.01% |
92,010
+4,169
| +5% | +$265K |
|
1040
89bio
ETNB
$1.23B
| $5.84M | ﹤0.01% |
383,588
-155,091
| -29% | -$2.36M |
|
1041
Intellia Therapeutics
NTLA
$1.24B
| $5.82M | ﹤0.01% |
156,088
+56,967
| +57% | +$2.12M |
|
1042
Vanguard Mid-Cap ETF
VO
$88.2B
| $5.78M | ﹤0.01% |
27,414
-11,494
| -30% | -$2.42M |
|
1043
Dentsply Sirona
XRAY
$2.71B
| $5.77M | ﹤0.01% |
146,894
-4,390
| -3% | -$172K |
|
|
JKS
1044
JinkoSolar
JKS
$1.3B
| $5.76M | ﹤0.01% |
112,877
+89,946
| +392% | +$4.59M |
|
|
BSX.PRA
1045
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $5.75M | ﹤0.01% |
47,500
+29,447
| +163% | +$3.56M |
|
1046
Curtiss-Wright
CW
$19.1B
| $5.75M | ﹤0.01% |
32,609
-2,284
| -7% | -$403K |
|
|
CTLT
1047
DELISTED
CATALENT, INC.
CTLT
| $5.73M | ﹤0.01% |
87,147
+5,665
| +7% | +$372K |
|
1048
Global X Robotics & Artificial Intelligence ETF
BOTZ
$2.88B
| $5.72M | ﹤0.01% |
224,496
-21,315
| -9% | -$544K |
|
|
SWN
1049
DELISTED
Southwestern Energy Company
SWN
| $5.72M | ﹤0.01% |
1,143,478
-183,385
| -14% | -$917K |
|
1050
Revolution Medicines
RVMD
$8.65B
| $5.71M | ﹤0.01% |
263,768
+156,876
| +147% | +$3.4M |
|